Bacteremic pneumonia in neutropenic patients with cancer: Causes, empirical antibiotic therapy, and outcome

Archives of Internal Medicine

Volumn 158, Issue 8, 1998, Pages 868-872

  Carratalà, Jordi ^a   Rosón, Beatriz ^a   Fernández Sevilla, Alberto ^a   Alcaide, Fernando ^a   Gudiol, Francesc ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; IMIPENEM; NORFLOXACIN; PENICILLIN G;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL PNEUMONIA; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; MALE; MORTALITY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS MITIS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

AGED; BACTEREMIA; CEFTAZIDIME; CEPHALOSPORINS; FEMALE; HUMANS; IMIPENEM; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PNEUMONIA, BACTERIAL; THIENAMYCINS; TREATMENT OUTCOME;

EID: 0032571826     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.8.868     Document Type: Article

References (32)

1. Farr BM. Prognosis and decisions in pneumonia. N Engl J Med. 1997;336: 288-289.
2. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med. 1995; 333:1619-1624.
3. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993;94:281-288.
4. Mundy LM, Auwaerter PG, Oldach D, et al. Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med. 1995;152:1309-1315.
5. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis. 1994;18:501-513.
6. Niederman MS, Bass JB, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis assessment of severity and initial antibiotic therapy. Am Rev Respir Dis. 1993;148:1418-1426.
7. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64:328-340.
8. Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis. 1990; 161:381-396.
9. EORTC International Antimicrobial Therapy Cooperative Group. Gram-positive bacteraemia in granulocytopenic cancer patients. Eur J Cancer 1990;26: 569-574.
10. Shlaes DM, Binczewski B, Rice LB. Emerging antimicrobial resistance and the immunocompromised host. Clin infect Dis. 1993;17(suppl 2):527-536.
11. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drugresistant pneumococcal infections in the United States. JAMA. 1994;271: 1831-1835.
12. Pallares R, Liñares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med. 1995;333:474-480.
13. Carratala J, Alcaide F, Fernández-Sevilla A, Corbella X, Liñares J, Gudiol F. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin Infect Dis. 1995;20: 1169-1173.
14. Doern GV, Ferraro MJ, Brueggemann AB, Ruoft KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States, Antimicrob Agents Chemother. 1996;40:891-894.
15. Inagaki J, Rodriguez V, Bodey GP. Causes of death in cancer patients. Cancer. 1974;33:568-573.
16. Chang H, Rodriguez V, Narboni G, Bodey GP, Luna MA, Freireich EJ. Causes of death in adults with acute leukemia. Medicine. 1976;55:259-268.
17. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Sixth Informational Supplement. Villanova, Pa: National Committee for Clinical Laboratory Standards: 1995:M100S6/M7-A3.
18. Sickles EA, Young VM, Greene WH, Wiernick PH. Pneumonia in acute leukemia. Ann Intern Med. 1973;79:528-534.
19. Valdivieso M, Gil-Extremera B, Zornoza J, Rodriguez V, Bodey GP. Gram negative bacillary pneumonia in the compromised host. Medicine. 1977;56:241-254.
20. Pennigton JE, Feldman NT. Pulmonary infiltrates and fever in patients with hematologic malignancy: assessment of transbronchial biopsy. Am J Med. 1977; 62:581-587.
21. Pannuti CS, Gingrich RD, Pfaller MA, Wenzel RP. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. J Clin Oncol. 1991;9:77-84.
22. Lossos IS, Breuer R, Or R, et al. Bacterial pneumonia in recipients of bone marrow transplantation: a five year prospective study. Transplantation. 1995;60: 672-678.
23. Bodey GP, Rodriguez V, Chang H, Narboni G. Fever and infection in leukemic patients: a study of 494 consecutive patients. Cancer. 1978;41:1610-1622.
24. Rubin M, Hathorn JW, Marshall D, Gress J, Steinberg M, Pizzo PA. Grampositive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med. 1988;108:30-35.
25. Awada A, van der Auwera P, Meunier F, Daneau D, Klastersky J. Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis. 1992;15: 33-48.
26. González-Barca E, Fernández-Sevilla A, Carratalà J, Grañena A, Gudiol F. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis. 1996;15:291-296.
27. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis. 1992; 14:1201-1207.
28. Bochud PY, Eggiman PH, Calandra TH, Van Melle G, Saghafi L, Francioli P. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis. 1994;18:25-31.
29. Cruciani M, Rampazzo R, Malena M, et al. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clin Infect Dis. 1996; 23:795-805.
30. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med. 1993;328:1323-1332.
31. Bodey GP. Empirical antibiotic therapy for fever in neutropenic patients. Clin Infect Dis. 1993;17(suppl 2):378-384.
32. Johnson AP, Uttley AHC, Woodford N, George RC. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev. 1990;3: 280-291.